As of November 2024 Galectin Therapeutics has a market cap of €0.16 Billion. This makes Galectin Therapeutics the world's 8130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of Galectin Therapeutics was reported to be: